APC anti-mouse CD4 Antibody

Pricing & Availability
Clone
GK1.5 (See other available formats)
Regulatory Status
RUO
Other Names
L3T4, T4
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
GK1.5_APC_102110
C57BL/6 mouse splenocytes were stained with CD4 (clone GK1.5) APC (filled histogram) or rat IgG2b, κ APC isotype control (open histogram).
  • GK1.5_APC_102110
    C57BL/6 mouse splenocytes were stained with CD4 (clone GK1.5) APC (filled histogram) or rat IgG2b, κ APC isotype control (open histogram).
Compare all formats See APC spectral data
Cat # Size Price Quantity Check Availability Save
100411 25 µg 39 CHF
Check Availability


Need larger quantities of this item?
Request Bulk Quote
100412 100 µg 132 CHF
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD4 is a 55 kD protein also known as L3T4 or T4. It is a member of the Ig superfamily, primarily expressed on most thymocytes, a subset of T cells, and weakly on macrophages and dendritic cells. It acts as a coreceptor with the TCR during T cell activation and thymic differentiation by binding MHC class II and associating with the protein tyrosin kinase, lck.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse CTL clone V4
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with APC under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The CD4 antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Red Laser (633 nm)
Application Notes

Additional reported applications (for the relevant formats) include: blocking of CD4+ T cell activation1,4,11, thymocyte costimulation3, in vitro and in vivo depletion2,5-8, blocking of egg-sperm cell adhesion1,4, immunohistochemical staining of acetone-fixed frozen sections9,10, immunoprecipitation1,2, and spatial biology (IBEX)12,13. The GK1.5 antibody is able to block CD4 mediated cell adhesion and T cell activation. Binding of GK1.5 antibody to CD4 T cells can be blocked by RM4-5 antibody, but not RM4-4 antibody. For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Cat. No. 100442) with a lower endotoxin limit than standard LEAF™ purified antibodies (Endotoxin < 0.01 EU/µg).

Application References

(PubMed link indicates BioLegend citation)
  1. Dialynas DP, et al. 1983. J. Immunol. 131:2445. (Block, IP)
  2. Dialynas DP, et al. 1983. Immunol. Rev. 74:29. (IP, Deplete)
  3. Wu L, et al. 1991. J. Exp. Med. 174:1617. (Costim)
  4. Godfrey DI, et al. 1994. J. Immunol. 152:4783. (Block)
  5. Gavett SH, et al. 1994. Am. J. Respir. Cell. Mol. Biol. 10:587. (Deplete)
  6. Schuyler M, et al. 1994. Am. J. Respir. Crit. Care Med. 149:1286. (Deplete)
  7. Ghobrial RR, et al. 1989. Clin. Immunol. Immunopathol. 52:486. (Deplete)
  8. Israelski DM, et al. 1989. J. Immunol. 142:954. (Deplete)
  9. Zheng B, et al. 1996. J. Exp. Med. 184:1083. (IHC)
  10. Frei K, et al. 1997. J. Exp. Med. 185:2177. (IHC)
  11. Felix NJ, et al. 2007. Nat. Immunol. 8:388. (Block)
  12. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  13. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Glasner A,et al. 2017. Sci Rep.. 10.1038/s41598-017-12998-w. PubMed
  2. Contijoch EJ et al. 2019. eLife. 8 pii: e40553. PubMed
  3. Komuczki J, et al. 2019. Immunity. 50:1289. PubMed
  4. Kisielow J, et al. 2019. Nat Immunol. 1.286111111. PubMed
  5. Garo LP, et al. 2021. Nat Commun. 12:2419. PubMed
  6. Chen N, et al. 2021. Front Immunol. 12:756423. PubMed
  7. Berube A, et al. 2022. Viruses. 14:. PubMed
  8. Tan L, et al. 2022. Aging Dis. 13:1562. PubMed
  9. Hirata Y et al. 2018. Cell stem cell. 22(3):445-453 . PubMed
  10. Gerwing M, et al. 2020. Mol Imaging Biol. 1.959027778. PubMed
  11. Tan L, et al. 2022. Biochem Biophys Rep. 32:101351. PubMed
  12. Hong M, et al. 2021. Int J Mol Sci. 22:. PubMed
  13. Zhu W, et al. 2021. Onco Targets Ther. 14:2149. PubMed
  14. Geng Z, et al. 2021. Nat Commun. 12:6584. PubMed
  15. Zhang R, et al. 2021. Cell Mol Immunol. 18:1222. PubMed
  16. Zhu P, et al. 2012. J Cereb Blood Flow Metab. 0.482638889. PubMed
  17. Zhang S, et al. 2022. Acta Pharm Sin B. 12:3124. PubMed
  18. Schmidt V, et al. 2021. J Cell Biol. 220:. PubMed
  19. Choi H et al. 2019. Cell Rep. 27(3):806-819 . PubMed
  20. Zhang C, et al. 2022. J Extracell Vesicles. 11:e12209. PubMed
  21. Oh DS, et al. 2021. Autophagy. 17:2111. PubMed
  22. Gu H, et al. 2021. Immun Inflamm Dis. 9:1686. PubMed
  23. Ren J, et al. 2021. Theranostics. 11:304. PubMed
  24. Schiller M, et al. 2021. Immunity. 54(5):1022-1036.e8. PubMed
  25. Cai B, et al. 2021. Mol Cancer. 20:165. PubMed
  26. Helm M, et al. 2022. Life (Basel). 12:. PubMed
  27. Dolgova EV, et al. 2022. Int J Mol Sci. 23:. PubMed
  28. Liang Z, et al. 2021. J Cell Physiol. 236:4725. PubMed
  29. Tian X, et al. 2022. Front Immunol. 13:875236. PubMed
  30. Lu Y, et al. 2020. Cell. 180(6):1081-1097. PubMed
  31. Pan W et al. 2017. Immunity. 47(2):284-297 . PubMed
  32. Britton GJ et al. 2019. Immunity. 50(1):212-224 . PubMed
  33. Yang X, et al. 2019. Oncotarget. 10:4180. PubMed
  34. Jiang S, et al. 2020. Scand J Immunol. e12867:91. PubMed
  35. Alissafi T, et al. 2020. Cell Metabolism. 32(4):591-604.e7. PubMed
  36. Zhang X, et al. 2020. J Immunol. 205:1743. PubMed
  37. Oghumu S, et al. 2014. Immunology. 143: 109-119. PubMed
  38. Inoue M, et al. 2014. Proc Natl Acad Sci U S A. 111:5295. PubMed
  39. Lo W, Allen D 2012. Nat Immunol. 13:880. PubMed
  40. Li K, et al. 2022. J Immunother Cancer. 10:. PubMed
  41. Jia L, et al. 2022. Front Immunol. 13:897879. PubMed
  42. Hongu T, et al. 2022. Nat Cancer. 3:486. PubMed
  43. Zhan Y, et al. 2021. JCI Insight. 6:. PubMed
  44. Zhang Z, et al. 2021. Oncoimmunology. 10:1912472. PubMed
  45. He W et al. 2018. Immunity. 49(6):1175-1190 . PubMed
  46. Riffelmacher T et al. 2017. Immunity. 47(3):466-480 . PubMed
  47. Pein M, et al. 2020. Nat Commun. 11:1494. PubMed
  48. Canto F, et al. 2016. Sci Rep. 6:28573. PubMed
  49. Ben-Shaanan T, et al. 2016. Nat Med. 10.1038/nm.4133. PubMed
  50. Velázquez K, et al. 2016. Am J Physiol Gastrointest Liver Physiol. 311: G699 - G712. PubMed
  51. Wei SC, et al. 2020. Cancer Discov. . PubMed
  52. Khatun A, et al. 2021. J Exp Med. 218:. PubMed
  53. Si L, et al. 2022. Nat Biotechnol. 40:1370. PubMed
  54. Shin JE, et al. 2021. Heliyon. 7:e08433. PubMed
  55. Chen D, et al. 2020. Cancer Immunol Res. 8:883. PubMed
  56. Huang Y, et al. 2020. FASEB J. 34:1768. PubMed
  57. Aegerter H, et al. 2020. Nat Immunol. 0.975694444. PubMed
  58. Wu C, et al. 2014. J Mol Cell Cardiol. 76:33. PubMed
  59. Haase C, et al. 2022. Nat Methods. 19:1622. PubMed
  60. Freitas JT, et al. 2021. Pigment Cell Melanoma Res. 34:1084. PubMed
  61. Hu G, et al. 2022. Cell Death Dis. 13:640. PubMed
  62. Kotaki R, et al. 2020. Sci Rep. 10:13554. PubMed
  63. Wu L, et al. 2022. Theranostics. 12:842. PubMed
  64. Yue X, et al. 2019. Nat Commun. 10:2011. PubMed
  65. Niemann J, et al. 2019. Nat Commun. 10:3236. PubMed
  66. Chisolm DA et al. 2019. Immunity. 51(1):155-168 . PubMed
  67. Leisegang M, et al. 2016. Clin Cancer Res. 22: 2734 - 2743. PubMed
  68. Li J, et al. 2020. Elife. 9:00. PubMed
  69. Abdul Pari AA, et al. 2020. Cancer Res. 80:2586. PubMed
  70. Wang Y, et al. 2021. Front Immunol. 12:654463. PubMed
  71. Ng SS, et al. 2020. Nat Immunol. 21:1205. PubMed
  72. Jing Y, et al. 2020. Sci Adv. 6:eaax9455. PubMed
  73. St Clair JB, et al. 2017. PLoS One. 12:e0170556. PubMed
  74. Qi S et al. 2016. eLife. 5 pii: e14756. PubMed
  75. Ren G et al. 2017. Molecular cell. 67(6):1049-1058 . PubMed
  76. Garo LP, et al. 2019. Cell Rep. 28:3353. PubMed
  77. Ishidome T et al. 2017. EBioMedicine. 22:89-99 . PubMed
  78. Yang J, et al. 2020. Nature. 586:572. PubMed
  79. Markey K, et al. 2014. J Immunol. 192:5426. PubMed
  80. Tang X, et al. 2022. Cell Rep. 41:111673. PubMed
  81. Takano T, et al. 2020. Front Immunol. 11:1555. PubMed
  82. Hu J, et al. 2019. Mol Ther Nucleic Acids. 16:650. PubMed
  83. Zhang H, et al. 2019. Mol Cell. 76:110. PubMed
  84. Gibbins J, et al. 2014. Blood. 124:2953. PubMed
  85. Nakajima-Adachi H, et al. 2017. PLoS One. 12(2):e0172795. PubMed
  86. Vaena S, et al. 2021. Cell Reports. 35(5):109076. PubMed
  87. Kruta M, et al. 2021. Cell Stem Cell. :. PubMed
  88. Alhosaini K, et al. 2021. Brain Sci. :11. PubMed
  89. Tan YY, et al. 2021. Exp Ther Med. 22:1368. PubMed
  90. Zhou Z, et al. 2022. Infect Immun. 90:e0045321. PubMed
  91. Toyama S, et al. 2021. Int J Mol Sci. 22:. PubMed
  92. Nikolos F, et al. 2022. Nat Commun. 13:1487. PubMed
  93. Coronel MM, et al. 2020. Sci Adv. 6:eaba5573. PubMed
  94. Bosnjak B, et al. 2019. Front Immunol. 10:840. PubMed
  95. Zou D, et al. 2020. EBioMedicine. 52:102652. PubMed
  96. Chatterjee S et al. 2017. Cell metabolism. 27(1):85-100 . PubMed
  97. Yan J, et al. 2020. Cell Rep. 107820:31. PubMed
  98. Clemens E, et al. 2015. J Immunol. 194:898. PubMed
  99. Wang R, et al. 2022. Front Immunol. 13:947756. PubMed
  100. Li Z, et al. 2021. MBio. 12:e0254221. PubMed
  101. Frost JN, et al. 2021. Med (N Y). 2:164. PubMed
  102. Anderson AE, et al. 2022. NPJ Regen Med. 7:6. PubMed
  103. Daneshmandi S, et al. 2021. Elife. 10:. PubMed
  104. Lu J, et al. 2021. Cell Death Discov. 7:165. PubMed
  105. Hu Y, et al. 2021. Cell Death Dis. 12:743. PubMed
  106. Chulpanova DS, et al. 2021. Biology (Basel). 10:. PubMed
  107. Watson MJ, et al. 2021. Nature. 591:645. PubMed
  108. Zhang Q, et al. 2021. Front Cell Dev Biol. 9:655552. PubMed
  109. Xiao Y, et al. 2022. Nat Commun. 13:758. PubMed
  110. Dulken BW, et al. 2019. Nature. 571:205. PubMed
  111. Burgener SS, et al. 2019. Cell Rep. 27:3646. PubMed
  112. Shen DD, et al. 2022. Mol Cancer. 21:75. PubMed
  113. He C, et al. 2022. Nat Commun. 13:5459. PubMed
  114. Kwok T, et al. 2022. Front Aging. 3:838943. PubMed
  115. Miyauchi E, et al. 2020. Nature. 585:102. PubMed
  116. Alexander Mildner et al. 2017. Immunity. 46(5):849-862 . PubMed
  117. Yu X, et al. 2013. Cancer Res. 73:2093. PubMed
  118. X X, et al. 2016. J Immunol . 197: 1683-1691. PubMed
  119. Gomzikova MO, et al. 2020. Pharmaceutics. 12:00. PubMed
  120. Daneshmandi S, et al. 2021. Cell Reports. 34(10):108831. PubMed
  121. Wedekind MF, et al. 2021. iScience. 24(7):102759. PubMed
  122. Wang L, et al. 2021. Sci Adv. 7:eabj4796. PubMed
  123. Tsai HI, et al. 2021. EMBO Mol Med. 13:e12834. PubMed
  124. Zhu S, et al. 2022. EBioMedicine. 80:104060. PubMed
  125. Garcia-Dominguez D, et al. 2022. Front Immunol. 13:948335. PubMed
  126. Zhang Y, et al. 2021. Commun Biol. 344:4. PubMed
  127. Montero-Barrera D, et al. 2015. BioMed Res Int. 2015 615865. PubMed
  128. Ma Q, et al. 2022. Vaccines (Basel). 10:. PubMed
  129. Kanatsu-Shinohara M, et al. 2022. J Reprod Dev. Online ahead of print. PubMed
  130. Georgiadou A, et al. 2022. Elife. 11:. PubMed
  131. Xiao Y, et al. 2021. Cell. 184:6037. PubMed
  132. Yang Z, et al. 2021. Nat Commun. 12:4299. PubMed
  133. Jia H, et al. 2018. Int J Oncol. 53:949. PubMed
  134. Gaya M et al. 2018. Cell. 172(3):517-533 . PubMed
  135. Hayashida E, et al. 2019. J Neuroinflammation. 0.789583333. PubMed
  136. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  137. Hosaka K, et al. 2020. Nat Commun. 3.030555556. PubMed
  138. Lo W, et al. 2014. Elife. 14:1457. PubMed
  139. Singhal P, et al. 2016. Proc Natl Acad Sci U S A. 113: 122 - 127. PubMed
  140. Zheng Z, et al. 2021. Biomed Res Int. 2021:5535578. PubMed
  141. Rui J, et al. 2021. Nat Commun. 12:5074. PubMed
  142. Zhang Z, et al. 2020. Nature. 579:415. PubMed
  143. Yang N, et al. 2022. Nat Commun. 13:2336. PubMed
  144. Lavoie S, et al. 2020. Gastroenterology. 158:1359. PubMed
  145. Hidalgo San Jose L, et al. 2020. Cell Rep. 30:69. PubMed
  146. Liang Z, et al. 2017. Autophagy. 14:505. PubMed
  147. Lu Y, et al. 2018. Cancer Cell. 33:1048. PubMed
  148. Ando T, et al. 2017. Inflammation. 10.1007/s10753-017-0613-6. PubMed
  149. Siolas D, et al. 2021. Cell Reports. 36(8):109578. PubMed
  150. Yu H, et al. 2015. PLoS One. 10: 0143001. PubMed
  151. Charlton J, et al. 2015. PLoS One. 10:119200. PubMed
  152. Rosen SF, et al. 2022. Genome Med. 14:108. PubMed
  153. Sun Y, et al. 2022. iScience. 25:104846. PubMed
  154. Ma C, et al. 2021. Mol Metab. 47:101170. PubMed
  155. Su M, et al. 2018. Immunol Cell Biol. 9:2448. PubMed
  156. Albaghdadi AJH, et al. 2019. Sci Rep. 9:6528. PubMed
  157. Caetano MS, et al. 2019. Clin Cancer Res. 25:7576. PubMed
  158. Kashiwakura Y, et al. 2020. Clinical & Experimental Immunology. 202(1):119-135. PubMed
  159. Schadler K, et al. 2014. Cancer Res. 74:2171. PubMed
  160. L M, et al. 2016. Brain. 139: 1939-1957. PubMed
  161. Angela M, et al. 2016. Nat Commun. 7:13683. PubMed
  162. Luo Z, et al. 2020. J Virol. 94:00:00. PubMed
  163. Wu L, et al. 2020. Cancer Immunol Res. 710:8. PubMed
  164. Wang K, et al. 2021. Nat Commun. 12:4558. PubMed
  165. Mazumder S, et al. 2021. Heliyon. 7:e08124. PubMed
  166. Zhang M, et al. 2022. iScience. 25:104490. PubMed
  167. Caporarello N, et al. 2022. Nat Commun. 13:4170. PubMed
  168. Fusciello M, et al. 2019. Nat Commun. 4.407638889. PubMed
  169. Chen S, et al. 2018. Nat Commun. 9:5298. PubMed
  170. Aurélien Trompette et al. 2018. Immunity. 48(5):992-1005 . PubMed
  171. Fan X, et al. 2014. PLoS One. 9:107638. PubMed
  172. Liang Z, et al. 2022. iScience. 25:105233. PubMed
  173. Yang H, et al. 2022. Viruses. 14:. PubMed
  174. He C, et al. 2021. Immunol Cell Biol. 99:611. PubMed
  175. Sethuraman SN, et al. 2020. Theranostics. 10:3397. PubMed
  176. Okubo A, et al. 2021. Int J Mol Sci. 23:. PubMed
  177. Nakazawa S, et al. 2020. Sci Rep. 10:14559. PubMed
RRID
AB_312696 (BioLegend Cat. No. 100411)
AB_312697 (BioLegend Cat. No. 100412)

Antigen Details

Structure
Ig superfamily, 55 kD
Distribution

Majority of thymocytes, T cell subset

Function
TCR co-receptor, T cell activation
Ligand/Receptor
MHC class II molecule
Cell Type
Dendritic cells, T cells, Thymocytes, Tregs
Biology Area
Immunology
Molecular Family
CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Bierer BE, et al. 1989. Annu. Rev. Immunol. 7:579.
3. Janeway CA. 1992. Annu. Rev. Immunol. 10:645.

Gene ID
12504 View all products for this Gene ID
UniProt
View information about CD4 on UniProt.org

Related FAQs

I am unable to see expression of T cell markers such as CD3 and CD4 post activation.
TCR-CD3 complexes on the T-lymphocyte surface are rapidly downregulated upon activation with peptide-MHC complex, superantigen or cross-linking with anti-TCR or anti-CD3 antibodies. PMA/Ionomycin treatment has been shown to downregulate surface CD4 expression. Receptor downregulation is a common biological phenomenon and so make sure that your stimulation treatment is not causing it in your sample type.

Other Formats

View All CD4 Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse CD4 GK1.5 FC
Biotin anti-mouse CD4 GK1.5 FC, IHC-F, ICC
FITC anti-mouse CD4 GK1.5 FC, IHC-F, ICC
PE anti-mouse CD4 GK1.5 FC
PE/Cyanine5 anti-mouse CD4 GK1.5 FC
Purified anti-mouse CD4 GK1.5 FC, IHC-F, ICC, IP, Costim, Block, Depletion
PE/Cyanine7 anti-mouse CD4 GK1.5 FC
APC/Cyanine7 anti-mouse CD4 GK1.5 FC
Alexa Fluor® 647 anti-mouse CD4 GK1.5 FC, IHC-F, ICC
Alexa Fluor® 488 anti-mouse CD4 GK1.5 FC, IHC-F, ICC
Pacific Blue™ anti-mouse CD4 GK1.5 FC
Alexa Fluor® 700 anti-mouse CD4 GK1.5 FC
PerCP anti-mouse CD4 GK1.5 FC
PerCP/Cyanine5.5 anti-mouse CD4 GK1.5 FC
Brilliant Violet 421™ anti-mouse CD4 GK1.5 FC, ICC, IHC-F
Ultra-LEAF™ Purified anti-mouse CD4 GK1.5 FC, Block, Costim, Depletion, IHC, IP
Alexa Fluor® 594 anti-mouse CD4 GK1.5 IHC-F, FC, ICC, SB
Brilliant Violet 711™ anti-mouse CD4 GK1.5 FC
Brilliant Violet 510™ anti-mouse CD4 GK1.5 FC, IHC-F, ICC
Brilliant Violet 605™ anti-mouse CD4 GK1.5 FC
Brilliant Violet 785™ anti-mouse CD4 GK1.5 FC
PE/Dazzle™ 594 anti-mouse CD4 GK1.5 FC
APC/Fire™ 750 anti-mouse CD4 GK1.5 FC
GoInVivo™ Purified anti-mouse CD4 GK1.5 FC
Brilliant Violet 750™ anti-mouse CD4 GK1.5 FC
Brilliant Violet 650™ anti-mouse CD4 GK1.5 FC
Spark Blue™ 550 anti-mouse CD4 GK1.5 FC
Spark NIR™ 685 anti-mouse CD4 GK1.5 FC
KIRAVIA Blue 520™ anti-mouse CD4 GK1.5 FC
PE/Fire™ 640 anti-mouse CD4 GK1.5 FC
APC/Fire™ 810 anti-mouse CD4 GK1.5 FC
PE/Fire™ 700 anti-mouse CD4 GK1.5 FC
Spark Violet™ 538 anti-mouse CD4 GK1.5 FC
Spark YG™ 593 anti-mouse CD4 GK1.5 FC
Spark Blue™ 574 anti-mouse CD4 Antibody GK1.5 FC
Spark UV™ 387 anti-mouse CD4 GK1.5 FC
Go To Top Version: 1    Revision Date: 11.30.2012

For research use only. Not for diagnostic use. Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products.

 

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/ordering#license). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.

 

BioLegend Inc., 8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

  • APC anti-mouse CD4

  • Biotin anti-mouse CD4

  • FITC anti-mouse CD4

  • PE anti-mouse CD4

  • PE/Cyanine5 anti-mouse CD4

  • Purified anti-mouse CD4

  • PE/Cyanine7 anti-mouse CD4

  • APC/Cyanine7 anti-mouse CD4

  • Alexa Fluor® 647 anti-mouse CD4

  • Alexa Fluor® 488 anti-mouse CD4

  • Pacific Blue™ anti-mouse CD4

  • Alexa Fluor® 700 anti-mouse CD4

  • PerCP anti-mouse CD4

  • PerCP/Cyanine5.5 anti-mouse CD4

  • Brilliant Violet 421™ anti-mouse CD4

  • Ultra-LEAF™ Purified anti-mouse CD4

  • Alexa Fluor® 594 anti-mouse CD4

  • Brilliant Violet 711™ anti-mouse CD4

  • Brilliant Violet 510™ anti-mouse CD4

  • Brilliant Violet 605™ anti-mouse CD4

  • Brilliant Violet 785™ anti-mouse CD4

  • PE/Dazzle™ 594 anti-mouse CD4

  • APC/Fire™ 750 anti-mouse CD4

  • GoInVivo™ Purified anti-mouse CD4

  • Brilliant Violet 750™ anti-mouse CD4

  • Brilliant Violet 650™ anti-mouse CD4

  • Spark Blue™ 550 anti-mouse CD4

  • Spark NIR™ 685 anti-mouse CD4

  • KIRAVIA Blue 520™ anti-mouse CD4

  • PE/Fire™ 640 anti-mouse CD4

  • APC/Fire™ 810 anti-mouse CD4

  • PE/Fire™ 700 anti-mouse CD4

  • Spark Violet™ 538 anti-mouse CD4

  • Spark YG™ 593 anti-mouse CD4

  • Spark Blue™ 574 anti-mouse CD4 Antibody

  • Spark UV™ 387 anti-mouse CD4

ProductsHere

Login / Register
Remember me
Forgot your password? Reset password?
Create an Account